About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 636 entries already.
Entries by Max
Newsletter 19/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! After two weeks of indigestion from new clinical trials and preclinical studies due to the international conferences AACR 2025 and AUA 2025, we’re back to a more modest amount of information—but no less interesting because of it! Stay strong […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer olaparib oncolytic virus PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy
Latest Posts
- QLS2401: A Trispecific PSMA/STEAP1/CD3 T‑Cell Engager for mCRPC March 27, 2026
- Antibody MQI‑201: Turning Cold Tumors Hot in Advanced Cancer March 26, 2026
- Bvax in Prostate Cancer: A B‑Cell Therapy That Penetrates Immune‑Excluded Tumors March 26, 2026
- Immune‑transcriptomic correlates of response to alpha‑ versus beta‑emitting PRRT in neuroendocrine tumors March 26, 2026
